Review
Copyright ©The Author(s) 2015.
World J Clin Oncol. Dec 10, 2015; 6(6): 237-251
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.237
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 The extent of lymphadenectomy currently proposed for urothelial carcinoma of the upper urinary tract.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Benefit of staging lymphadenectomy by stratification of patients according to lymph node status in our institute. CSS: Cancer-specific survival.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Therapeutic benefit of lymphadenectomy according to the extent of lymphadenectomy in our institute. LND: Lymphadenectomy; CSS: Cancer-specific survival.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Patient survival in a non-randomized prospective study according to the location of the primary tumor. LND: Lymphadenectomy; CSS: Cancer-specific survival; RFS: Recurrence-free survival; OS: Overall survival.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Recurrence pattern in regional nodes according to the extent of lymphadenectomy in patients with renal pelvic cancer. LND: Lymphadenectomy; LN: Lymph node.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 The influence of the number of lymph nodes removed on cancer-specific survival. LND: Lymphadenectomy; CSS: Cancer-specific survival; LNs: Lymph nodes.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 The incidence of lymphatic metastases according to the primary tumor stage. LN: Lymph node.